Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Edesa Biotech, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 18 | 17 | −1 |
| Shares | 161.3K | 207.5K | +46.2K (+28.6%) |
| Value | $718.2K | $350.1K | −$368.1K (−51.3%) |
New holders (3)
Institutions that held Edesa Biotech, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 40,944 | $69.6K | 0.00% |
| Two Sigma Securities, LLC | 15,313 | $25.7K | 0.00% |
| Dogwood Wealth Management LLC | 1 | $2 | 0.00% |
Sold out (4)
Institutions that held Edesa Biotech, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Dimensional Fund Advisors LP | 11,333 | $50.4K |
| Avion Wealth | 242 | $1.00K |
| Federation des caisses Desjardins du Quebec | 19 | $85 |
| National Bank of Canada | 8 | $36 |